Authors


Rick S. Mathis, PhD

Latest:

A Meta-analysis Update: Percutaneous Coronary Interventions

Meta-analyses of percutaneous coronary interventions in stable coronary artery disease are updated to include 2 recent large randomized controlled trials.


Timo Klaukka, MD, PhD&dagger

Latest:

Pattern of Statin Use Among 10 Cohorts of New Users From 1995 to 2004: A Register-Based Nationwide Study

One-year persistence among new users of statins in Finland improved from 1995 to 1998, after which no substantial changes were observed up to 2004.


Boaz Hirshberg, MD

Latest:

Mortality, Outcomes, and Healthcare Costs in T2DM Patients at Risk for Cardiovascular Disease

Targeting glucose control and managing cardiovascular (CV) risk factors may prevent future CV events, and have positive downstream impact by reducing costs to healthcare stakeholders.


Trent McLaughlin, BSc(Pharm), PhD

Latest:

Cost of Care for Malignant and Benign Renal Masses

Methods for better identifying malignant versus benign disease before nephrectomy could provide significant benefits to patients and payers.




Daniel J. Peterson, MA, MS

Latest:

Quality Measurement of Medication Monitoring in the Meaningful Use Era

Shifting from claims to integrated electronic health records to calculate quality metrics will improve reported quality attributable to data capture changes, not true quality improvements.


Hadi Kharrazi, MD, PhD

Latest:

Assessing Electronic Health Record Implementation Challenges Using Item Response Theory

It is unclear which barriers cause the greatest threats to the successful implementation of an electronic health record (EHR). This paper prioritizes the potential threats to EHR adoption using a novel analytic strategy: item response theory.


Chief Executive Officer, America's Health Insurance Plans

Latest:

Innovation in Plain Sight

Innovations are powering the evolution of patient-centered care, and health plans are at the center of this innovation story.






Douglas W. Mapel, MD, MPH

Latest:

Can Outpatient Pharmacy Data Identify Persons With Undiagnosed COPD?

Algorithms based on managed care pharmacy data can efficiently identify persons at risk for undiagnosed chronic obstructive pulmonary disease.



Christopher Miller Rosales, MS

Latest:

Feasibility of Expanded Emergency Department Screening for Behavioral Health Problems

This feasibility study of expanded emergency department screening identified a high prevalence of behavioral health conditions. Screening was successfully integrated into emergency visit idle times.






Benjamin Linas, MD

Latest:

Increasing Hepatitis C Screening in a Large Integrated Health System: Science and Policy in Concert

The success of recommendations to improve screening often rests on the availability of efficacious therapies, coverage policies, and other factors that enable and justify screening.






Samuel W. Bott, BS

Latest:

Pricing of Monoclonal Antibody Therapies: Higher If Used for Cancer?

The annual price of monoclonal antibody therapies used in oncology and hematology is about $100,000 higher than those used in other disease states.



Dawn Provenzale, MD, MS

Latest:

Variability in Resource Use: Diagnosing Colorectal Cancer

In a cohort of 449 patients with colorectal cancer in the VA health system, diagnostic resource use varied with facility, patient age, and patient presentation.


Matthew S. Kruszewski, PharmD

Latest:

Toyota Production System Quality Improvement Initiative Improves Perioperative Antibiotic Therapy

Use of Toyota production system methods as part of a nosocomial MRSA prevention initiative on a surgical unit improved quality of care in other areas.


AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo